As of Feb 11
| +0.05 / +2.53%|
The 1 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a -1.48% decrease from the last price of 2.03.
The current consensus among 2 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.